Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05610592

Tumor Budding in Patients With Colorectal Cancer Under Different MMR Status

Conditions: Tumor Budding, Rectal Cancer

Sex: All
Ages: 18 Years – 80 Years
Enrollment: 480
Sponsor: Sun Yat-sen University

Location: China

Summary

This study investigates the ability of tumor budding to identify prognosis in different MMR states and different levels of tumor lymphocyte infiltration. Tumor budding is usually defined as an isolated single cancer cell or a cluster of up to four cancer cells located at the front of an infiltrating tumor.

Eligibility Criteria

Inclusion Criteria:Confirmed colorectal adenocarcinoma cancer pathologicallyUnderwent primary surgeryWith records for tumor budding stainingWilling and able to provide written informed consent for participation in this studyNon-complicated primary tumor (complete obstruction, perforation, bleeding)Exclusion Criteria:With distant metastases at the time of initial diagnosisWithout a complete pathological dateHereditary colorectal cancerSubjects with a history of a prior malignancy within the past 5 years, except for adequately treated basal cell or squamous cell skin cancer

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05610592). StuddyBuddy aggregates publicly available trial information.